Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 4/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 4/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 4/20 | 0.39 |
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | BRD2 | P25440 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14559892 | 0.93 | BRD4 (0.39) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL12443428 | 0.90 | BRD4 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL1440028 | 0.90 | BRD4 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL11382367 | 0.88 | BRD4 (0.42) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL2363506 | 0.88 | BRD4 (0.48) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL600282 | 0.87 | BRD4 (0.52) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL3053956 | 0.85 | BRD4 (0.46) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL20377259 | 0.83 | HRH3 (0.39) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL11560817 | 0.81 | BRD4 (0.37) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL2514082 | 0.80 | BRD4 (0.33) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025065089-A1 | METHOD OF SYNTHESIZING A 1,6-DIAZABICYCLO[4.4.4]TETRADECAN-1,6-IUM CATIONIC STRUCTURE, USE OF SAID CATIONIC STRUCTURE IN ELECTROCHEMICAL APPLICATIONS, AND POLYMERS COMPRISING SAID CATIONIC STRUCTURE | SIMON FRASER UNIVERSITY (CA) | 2025-04-03 | — | — | WO | disclosed |
| US-20120238749-A1 | INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238749-A1 | INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME | IL1B, IL1A, IL1R1 | CHRM2 4499/4885CHRM4 4722/4885CHRM5 4440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.